Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineages
Preprint
Abstract
There is now increasing recognition of the important role of androgen receptor (AR) in modulating immune function. To gain a comprehensive understanding of the effects of AR activity on cancer immunity, we employed a computational approach to profile AR activity in 33 human tumor types using RNA-Seq datasets from The Cancer Genome Atlas. Our pan-cancer analysis revealed that the genes most negatively correlated with AR activity across cancers are involved in active immune system processes. Importantly, we observed a significant negative correlation between AR activity and IFNγ pathway activity at the pan-cancer level. Indeed, using a matched biopsy dataset from subjects with prostate cancer before and after AR-targeted treatment, we verified that inhibiting AR enriches immune cell abundances and is associated with higher IFNγ pathway activity. Furthermore, by analyzing immunotherapy datasets in multiple cancers, our results demonstrate that low AR activity was significantly associated with a favorable response to immunotherapy. Together, our data provide a comprehensive assessment of the relationship between AR signaling and tumor immunity.Keywords
This publication has 84 references indexed in Scilit:
- Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancerCancer Cell, 2023
- Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistanceCancer Letters, 2021
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCancer Cell, 2020
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsCell, 2018
- Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaCancer Cell, 2017
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyCell, 2016
- Androgen receptor immunohistochemistry in genitourinary neoplasmsInternational Urology and Nephrology, 2014
- Androgen Receptor Influences on Body Defense System via Modulation of Innate and Adaptive Immune SystemsThe American Journal of Pathology, 2012
- Modeling Survival Data: Extending the Cox Model2000
- The nuclear receptor superfamily: The second decadeCell, 1995